Bluevoodoo, Debra, Jibacao, et.al.: Bio-tech appears to have regained favor, so without a doubt such as BIOM are doing well right now. As has been said by others, including the talking heads of such as CNBC, after years of development the bio-tech sector "seeds" look ready to break through the soil with some end products of high efficacy. And Bluevoo's article probably put some nice focus on BIOM, too.
All-n-all I still see no reason to abandon this speculation. The bias is nicely positive(after a weee bit of backing & filling), such news as has been gleaned indicates their "Lexus" product, Theratope, is on track, and if I didn't know better I'd say BIOM's under steady accumulation. It looks like things could look reeally great by years end. Meanwhile, I'm enjoying the ride.
Jib: I concur with others, thanks for all the excellent postings! Deb; I'm waaay beyond goosebumps. Do goose mountains apply? Heh!
And Colin; ain't that always the way? You exercise patience, patience, patience, end up saying "screw it", and the very next day guess who becomes the screwee? ;-) Been there, done that, and it'll probably happen again. Still, to mitigate the possibility 'tis always a good idea to maintain a diversified portfolio. You become less obsessive over one equity that way.
Now let's see how BIOM closes(speaking of obsessive).
John~ |
